Transaction DateRecipientSharesTypePriceValue
30th December 2020Thomas Woiwode1,347,709Open or private purchase$3.71$5,000,000.39
14th December 2020Thomas Woiwode12,783Other acquisition or disposition$0.00
20th October 2020Thomas Woiwode198,485Conversion of derivative$0.00
20th October 2020Thomas Woiwode200,000Open or private purchase$15.00$3,000,000.00
20th October 2020Thomas Woiwode463,959Conversion of derivative$0.00
20th October 2020Thomas Woiwode198,839Conversion of derivative$0.00
20th October 2020Thomas Woiwode2,145,991Conversion of derivative$0.00
20th October 2020Thomas Woiwode85,065Conversion of derivative$0.00
17th August 2020Laurent Fischer7,692Open or private purchase$13.00$99,996.00
17th August 2020Peter Soparkar7,692Open or private purchase$13.00$99,996.00
Avalanche Biotechnologies
Avalanche Biotechnologies logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.



Ticker: AAVL
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1501756
Employees:
Exchange: None
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
News